Novartis India Limited NOVARTIND.BO
NOVARTIND.BO
Novartis India Limited AMRUTANJAN.BO
Amrutanjan Health Care Limited AMRUTANJAN.NS
Amrutanjan Health Care Limited WINDLAS.NS
Windlas Biotech Limited WINDLAS.BO
Windlas Biotech Limited ALEMBICLTD.NS
Alembic Limited MOREPENLAB.NS
Morepen Laboratories Limited MOREPENLAB.BO
Morepen Laboratories Limited BLISSGVS.BO
Bliss GVS Pharma Limited BLISSGVS.NS
Bliss GVS Pharma Limited
Novartis India Limited AMRUTANJAN.BO
Amrutanjan Health Care Limited AMRUTANJAN.NS
Amrutanjan Health Care Limited WINDLAS.NS
Windlas Biotech Limited WINDLAS.BO
Windlas Biotech Limited ALEMBICLTD.NS
Alembic Limited MOREPENLAB.NS
Morepen Laboratories Limited MOREPENLAB.BO
Morepen Laboratories Limited BLISSGVS.BO
Bliss GVS Pharma Limited BLISSGVS.NS
Bliss GVS Pharma Limited
Performance
| Periode | NOVARTIND.BO | AMRUTANJAN.BO | AMRUTANJAN.NS | WINDLAS.NS | WINDLAS.BO | ALEMBICLTD.NS | MOREPENLAB.NS | MOREPENLAB.BO | BLISSGVS.BO | BLISSGVS.NS |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 4.62 % | 6.42 % | 6.78 % | -8.98 % | -9.18 % | -5.13 % | -21.50 % | -21.40 % | 20.74 % | 21.07 % |
| YTD | -5.33 % | -0.75 % | -0.43 % | -11.03 % | -11.16 % | -23.91 % | -38.33 % | -38.31 % | -14.11 % | -13.79 % |
| 1Y | -18.32 % | -3.30 % | -3.19 % | -5.97 % | -5.77 % | -16.66 % | -35.90 % | -35.81 % | 22.69 % | 22.98 % |
| 3Y | 26.77 % | -4.68 % | -4.49 % | 295.59 % | 295.31 % | 48.67 % | 81.22 % | 82.43 % | 104.70 % | 105.38 % |
| 5Y | 38.22 % | 75.73 % | 74.91 % | 128.13 % | 128.18 % | 6.39 % | 90.78 % | 90.60 % | -11.36 % | -11.48 % |
| 10Y | -6.46 % | 232.78 % | 233.12 % | 128.13 % | 128.18 % | 182.67 % | 157.05 % | 156.64 % | -14.37 % | -14.06 % |
| From the beginning | 273.93 % | 6 064.08 % | 1 582.38 % | 128.13 % | 128.18 % | 2 407.46 % | 139.65 % | -67.41 % | 59 830.83 % | 275.02 % |